About Company

At Serna Bio, we are employing a data-centric approach facilitated by AI to establish the principles that govern the interaction between RNA and small molecules. Our Discovery Platform fuels our pioneering small molecule programs aimed at proteins that have traditionally been considered unresponsive to drugs.